These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8484071)

  • 21. Classification of acute leukemias: reply from EGIL to Dr van Dongen.
    Bene MC; Castoldi G; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer MB
    Leukemia; 1996 Aug; 10(8):1363-4. PubMed ID: 8709644
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunophenotyping of acute leukaemias and non-Hodgkin's lymphoma--review of ongoing consensus protocols.
    Höffkes HG; Brittinger G; Franke A
    Eur J Med Res; 1996 Jun; 1(9):433-8. PubMed ID: 9438140
    [No Abstract]   [Full Text] [Related]  

  • 23. Neural network analysis of flow cytometry immunophenotype data.
    Kothari R; Cualing H; Balachander T
    IEEE Trans Biomed Eng; 1996 Aug; 43(8):803-10. PubMed ID: 9216152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
    Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama J; Orfao A;
    Cytometry B Clin Cytom; 2006 Jan; 70(1):1-9. PubMed ID: 16278833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry: basic concepts and clinical applications in immunodiagnostics.
    Goetzman EA
    Clin Lab Sci; 1993; 6(3):177-82. PubMed ID: 10151012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of immunophenotyping on management of acute leukemias.
    Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
    Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
    Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
    Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP
    Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New findings in the diagnosis of minimal residual disease in acute leukemia with emphasis on flow cytometry].
    Vosková D; Váleková L; Kubisz P
    Vnitr Lek; 1997 May; 43(5):332-6. PubMed ID: 9601859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
    Bacher U; Kern W; Schoch C; Schnittger S; Hiddemann W; Haferlach T
    Cancer; 2006 Feb; 106(4):839-47. PubMed ID: 16419072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flow cytometry--use in cell biology and benefits in clinical medicine].
    Clausen OP; Olsen G; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):489-95. PubMed ID: 10833942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
    Taylor CG; Stasi R; Bastianelli C; Venditti A; Del Poeta G; Amadori S; Sargent J
    Hematopathol Mol Hematol; 1996; 10(1-2):1-38. PubMed ID: 8792146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concurrence of cytochemical and immune patterns of different cell lines in cases of acute leukemia].
    Grignaschi VJ; Pérez Bianco R; Aixalá M; de Tezanos Pinto M
    Medicina (B Aires); 1996; 56(4):339-45. PubMed ID: 9138337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the phenotype and cellular DNA content in some leukemias by flow cytometry.
    Kusenda J; Glasová M; Babusíková O
    Neoplasma; 1995; 42(6):347-52. PubMed ID: 8592578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lineage ambiguity, infidelity, and promiscuity in immunophenotypically complex acute leukemias: genetic and morphologic correlates.
    Bagg A
    Am J Clin Pathol; 2007 Oct; 128(4):545-8. PubMed ID: 17875503
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
    Merle-Béral H; Boucheix C
    Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute lymphoblastic leukemia.
    Melnick SJ
    Clin Lab Med; 1999 Mar; 19(1):169-86, vii. PubMed ID: 10403080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Different types of leukemias].
    Cambier N; Charpentier A
    Soins; 2008 Mar; (723):42-3. PubMed ID: 18380311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.